The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Phenotypic clustering in MPZ mutations
Open accessAbstract
Myelin protein zero (MPZ) is a member of the immunoglobulin gene superfamily with single extracellular, transmembrane and cytoplasmic domains. Homotypic interactions between extracellular domains of MPZ adhere adjacent myelin wraps to each other. MPZ is also necessary for myelin compaction since mice which lack MPZ develop severe dysmyelinating neuropathies in which compaction is dramatically disrupted. MPZ mutations in humans cause the inherited demyelinating neuropathy CMT1B. Some mutations cause the severe neuropathies of infancy designated as Dejerine-Sottas disease, while others cause a 'classical' Charcot-Marie-Tooth (CMT) disease Type 1B (CMT1B) phenotype with normal early milestones but development of disability during the first two decades of life. Still other mutations cause a neuropathy that presents in adults, with normal nerve conduction velocities, designated as a 'CMT2' form of CMT1B. To correlate the phenotype of patients with MPZ mutations with their genotype, we identified and evaluated 13 patients from 12 different families with eight different MPZ mutations. In addition, we re-analysed the clinical data from 64 cases of CMT1B from the literature. Contrary to our expectations, we found that most patients presented with either an early onset neuropathy with signs and symptoms prior to the onset of walking or a late onset neuropathy with signs and symptoms at around age 40 years. Only occasional patients presented with a 'classical' CMT phenotype. Correlation of specific MPZ mutations with their phenotypes demonstrated that addition of either a charged amino acid or altering a cysteine residue in the extracellular domain caused a severe early onset neuropathy. Severe neuropathy was also caused by truncation of the cytoplasmic domain or alteration of an evolutionarily conserved amino acid. Taken together, these data suggest that early onset neuropathy is caused by MPZ mutations that significantly disrupt the tertiary structure of MPZ and thus interfere with MPZ-mediated adhesion and myelin compaction. In contrast, late onset neuropathy is caused by mutations that more subtly alter myelin structure and which probably disrupt Schwann cell-axonal interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin
Lemke, G., & Axel, R. (1985) · Cell · doi:10.1016/0092-8674(85)90198-9 · Cited by 527
Giese, K. P., Martini, R., Lemke, G., Soriano, P., & Schachner, M. (1992) · Cell · doi:10.1016/0092-8674(92)90591-y · Cited by 502
Total neuropathy score: Validation and reliability study
Cornblath, D. R., Chaudhry, V., Carter, K., Lee, D., Seysedadr, M., Miernicki, M., & Joh, T. (1999) · Neurology · doi:10.1212/wnl.53.8.1660 · Cited by 449
Martenson, R. E. (1992) · Medical Entomology and Zoology · Cited by 439
Nelis, E., & Van Broeckhoven, C. (1996) · European Journal of Human Genetics · doi:10.1159/000472166 · Cited by 431
Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A
Krajewski, K. M. (2000) · Brain · doi:10.1093/brain/123.7.1516 · Cited by 414
Shapiro, L., Doyle, J. P., Hensley, P., Colman, D. R., & Hendrickson, W. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80176-2 · Cited by 406
Warner, L. E., Hilz, M. J., Appel, S. H., Killian, J. M., Kolodny, E. H., Karpati, G., Carpenter, S., Watters, G. V., Wheeler, C., Witt, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80177-4 · Cited by 368
Role of myelin Po protein as a homophilic adhesion molecule
Filbin, M. T., Walsh, F. S., Trapp, B. D., Pizzey, J. A., & Tennekoon, G. I. (1990) · Nature · doi:10.1038/344871a0 · Cited by 294
The phenotypic manifestations of chromosome 17p11.2 duplication
Thomas, P. K., Marques, W., Davis, M. B., Sweeney, M. G., King, R. H., Bradley, J. L., Muddle, J. R., Tyson, J., Malcolm, S., & Harding, A. E. (1997) · Brain · doi:10.1093/brain/120.3.465 · Cited by 283
Boerkoel, C. F., Takashima, H., Garcia, C. A., Olney, R. K., Johnson, J., Berry, K., Russo, P., Kennedy, S., Teebi, A. S., Scavina, M., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10089 · Cited by 276
Self-citationD'Urso, D., Brophy, P. J., Staugaitis, S. M., Stewart Gillespie, C., Frey, A. B., Stempak, J. G., & Colman, D. R. (1990) · Neuron · doi:10.1016/0896-6273(90)90057-m · Cited by 274
Abnormal myelination in transplanted Trembler mouse Schwann cells
AGUAYO, A. J., ATTIWELL, M., TRECARTEN, J., PERKINS, S., & BRAY, G. M. (1977) · Nature · doi:10.1038/265073a0 · Cited by 224
De Jonghe, P., Timmerman, V., Ceuterick, C., Nelis, E., De Vriendt, E., Löfgren, A., Vercruyssen, A., Verellen, C., Van Maldergem, L., Martin, J.-J., et al. (1999) · Brain · doi:10.1093/brain/122.2.281 · Cited by 224
Gow, A., Southwood, C. M., & Lazzarini, R. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.925 · Cited by 218
Hayasaka, K., Himoro, M., Sawaishi, Y., Nanao, K., Takahashi, T., Takada, G., Nicholson, G. A., Ouvrier, R. A., & Tachi, N. (1993) · Nature Genetics · doi:10.1038/ng1193-266 · Cited by 205
ZEMAN, W., DEMYER, W., & FALLS, H. F. (1964) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-196404000-00008 · Cited by 179
Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene
Marrosu, M. G., Vaccargiu, S., Marrosu, G., Vannelli, A., Cianchetti, C., & Muntoni, F. (1998) · Neurology · doi:10.1212/wnl.50.5.1397 · Cited by 174
Gabreëls-Festen, A., Hoogendijk, J. E., Meijerink, P. H. S., et al. (1996) · Neurology · doi:10.1212/wnl.47.3.761 · Cited by 151
de Waegh, S. D., & Brady, S. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-06-01855.1990 · Cited by 144
Chapon, F., Latour, P., Diraison, P., Schaeffer, S., & Vandenberghe, A. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.6.779 · Cited by 125
Naef, R., & Suter, U. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0227 · Cited by 124
THE HYPERTROPHIC FORMS OF HEREDITARY MOTOR AND SENSORY NEUROPATHY
Ouvrier, R., McLeod, J. G., & Conchin, T. E. (1987) · Brain · doi:10.1093/brain/110.1.121 · Cited by 121
Effects of PMP22 duplication and deletions on the axonal cytoskeleton
Sahenk, Z., Chen, L., & Mendell, J. R. (1999) · Annals of Neurology · Cited by 96
Hereditary motor and sensory neuropathies: a biological perspective
Shy, M. E., Garbern, J. Y., & Kamholz, J. A. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00042-x · Cited by 87
Self-citationXu, W., Shy, M. E., Kamholz, J. A., Elferink, L. A., Xu, G., Lilien, J. E., & Balsamo, J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200107114 · Cited by 83
Self-citationDominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain.
Wong, M. H., & Filbin, M. T. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.134.6.1531 · Cited by 78
Congenital hypomyelination due to myelin protein zero Q215X mutation
Mandich, P., Mancardi, G., Varese, A., Soriani, S., Maria, E. D., Bellone, E., Bado, M., Gross, L., Windebank, A. J., Ajmar, F., et al. (1999) · Annals of Neurology · Cited by 57
Protein Zero Is Necessary for E-Cadherin-Mediated Adherens Junction Formation in Schwann Cells
Menichella, D. M., Arroyo, E. J., Awatramani, R. B., Xu, T., Baron, P., Vallat, J., Balsamo, J., Lilien, J. E., Scarlato, G., Kamholz, J. A., et al. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1041 · Cited by 53
Self-citationStreet, V. A., Meekins, G. D., Lipe, H., Seltzer, W. K., Carter, G. T., Kraft, G. H., & Bird, T. D. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00021-4 · Cited by 52
Ikegami, T., Nicholson, G. A., Ikeda, H., Ishida, A., Johnston, H. M., Wise, G. A., Ouvrier, R., & Hayasaka, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0705 · Cited by 49
Phosphorylation of myelin proteins: Recent advances
Eichberg, J., & Iyer, S. (1996) · Neurochemical Research · doi:10.1007/bf02527718 · Cited by 43
Selection for and Initiation of Continuous Subcutaneous Insulin Infusion
Hanås, R. (2002) · Hormone Research in Paediatrics · doi:10.1159/000053326 · Cited by 33
Blanquet-Grossard, F., Pham-Dinh, D., Dautigny, A., Latour, P., Bonnebouche, C., Diraison, P., Chapon, F., Chazot, G., & Vandenberghe, A. (1996) · Human Mutation · Cited by 28
Characterization of the Effect on Adhesion of Different Mutations in Myelin P0 Protein
Filbin, M. T., Zhang, K., Li, W., & Gao, Y. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08579.x · Cited by 25
Protein Misfolding as a Disease Determinant
Gow, A. (2004) · Elsevier eBooks · doi:10.1016/b978-012439510-7/50095-4 · Cited by 10
Cited by
Diagnosis, natural history, and management of Charcot–Marie–Tooth disease
Pareyson, D., & Marchesi, C. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70110-3 · Cited by 621
Charcot‐marie‐tooth disease subtypes and genetic testing strategies
Saporta, A. S. D., Sottile, S. L., Miller, L. J., Feely, S. M. E., Siskind, C. E., & Shy, M. E. (2011) · Annals of Neurology · doi:10.1002/ana.22166 · Cited by 542
Self-citationFridman, V, Bundy, B., Reilly, M. M., Pareyson, D., Bacon, C., Burns, J., Day, J., Feely, S., Finkel, R. S., Grider, T., et al. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308826 · Cited by 354
Self-citationCholesterol: A Novel Regulatory Role in Myelin Formation
Saher, G., Quintes, S., & Nave, K.-A. (2011) · The Neuroscientist · doi:10.1177/1073858410373835 · Cited by 144
The cytoplasmic tail of myelin protein zero induces morphological changes in lipid membranes
Krokengen, O. C., Touma, C., Mularski, A., Sutinen, A., Dunkel, R., Ytterdal, M., Raasakka, A., Mertens, H. D. T., Simonsen, A. C., & Kursula, P. (2024) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2024.184368 · Cited by 7
Metadata
- Authors
- Shy, M. E.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02-01
- Volume
- 127
- Issue
- 2
- Pages
- 371-384
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2133129464
- Cited by
- 298
- References
- 36
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.